For Patients
The goal of IMMUcan is to understand, how the immune system and tumours interact, and the impact of therapeutic interventions.
What is IMMUcan?
IMMUcan is a group of university and industry partners that collected tumour material and clinical data from several thousand cancer patients. The group generated biological data for research that is being made available for the scientific community.
Many opportunities for collaboration
What were the benefits for patients?
What were the benefits for patients?
| 01. |
Received additional information
|
| 02. |
Contributed to improving our understanding of cancer. |
| 03. |
Have a major impact on current and future treatments. |
Why be part of IMMUcan?
By taking part in this project, your clinician received additional information on your tumour. However, we could not guarantee that this had an immediate benefit for you. BUT your participation helped us better understand cancer and had a major impact on current and future treatments.
“IMMUcan stands for “Integrated iMMUnoprofiling
of large adaptive CANcer patient cohorts”
What is the aim of IMMUcan?
The tumour microenvironment consists of cancer cells, and other various non-tumour cells that are directly in or around the tumour, such as immune cells. The cancer research community believes that many factors within this environment influence how the tumour reacts to cancer treatments.
The hope is
What will IMMUcan deliver?
IMMUcan will deliver an understanding of the tumour microenvironment and how it evolves under the influence of cancer treatment, using tumour samples from some 3000 patients combined with clinical data.
Samples will include the tumour, stool, saliva or blood from patients diagnosed with colorectal, lung, head and neck, breast or renal cancers.
The clinical data and/or biological material contributed
to IMMUcan are not wasted.
The clinical data and/or biological material contributed to IMMUcan are used in further scientific research.
By selecting the tumour type, you could find the research projects that are using the contributed data and/or biological material.
As part of the IMMUcan project’s commitment to open science, certain imaging data (including multiplex immunofluorescence, mass cytometry and H&E images) will be uploaded to the Image Data Resource (IDR), a public research repository. Before sharing, the images are processed so that IDR does not receive any direct identifiers of participants. This sharing supports transparency and enables further research in line with the objectives of the IMMUcan project. For more details, contact us .